Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Liabilities and Shareholders Equity (2023 - 2025)

Astera Labs' Liabilities and Shareholders Equity history spans 3 years, with the latest figure at $1.5 billion for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 45.26% year-over-year to $1.5 billion, compared with a TTM value of $5.3 billion through Dec 2025, up 39.5%, and an annual FY2025 reading of $1.5 billion, up 45.26% over the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $1.5 billion at Astera Labs, up from $1.4 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $1.5 billion in Q4 2025, with the low at $196.3 million in Q4 2023.
  • Average Liabilities and Shareholders Equity over 3 years is $1.0 billion, with a median of $1.1 billion recorded in 2024.
  • Year-over-year, Liabilities and Shareholders Equity surged 437.21% in 2024 and then increased 29.69% in 2025.
  • Tracing ALAB's Liabilities and Shareholders Equity over 3 years: stood at $196.3 million in 2023, then surged by 437.21% to $1.1 billion in 2024, then soared by 45.26% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ALAB's Liabilities and Shareholders Equity are $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.3 billion (Q2 2025).